- China Nepstar Chain Drugstore (NYSE:NYSE:NPD) reports comparable-store sales rose 12.5% in Q4 primarily due to in-store promotional initiatives and improved average store output.
- Revenue contribution by products: Prescription drugs 21.7%; OTC 46.9%; Nutritional supplements 9.3%; Herbal products 4.3%; Convenience and other products 17.8%.
- Private label products sales represents ~12% of the total revenue & 16.3% of the gross profit.
- Gross margin rate expanded 230 bps to 44.7%.
- Inventory +5.1% Y/Y to RMB574.34M.
- Store count +33 Q/Q to 1,998.
More on China Nepstar Chain Drugstore's Q4
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
NPD | - | - |
China Nepstar Chain Drugstore Ltd. |